Using mobile apps to monitor patient symptoms during radiation therapy for cancer
Remote Monitoring of Patient Reported Outcomes to Improve the Efficacy of the Acute Phase Radiotherapy Review Process
This study tests whether a mobile app can help people with breast and prostate cancer report their symptoms during radiation therapy so doctors can better manage their care and improve their quality of life.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 124 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Health Network, Toronto Academic / other |
| Drugs / interventions | radiation, chemotherapy |
| Locations | 1 site (Toronto, Ontario) |
| Trial ID | NCT06274892 on ClinicalTrials.gov |
What this trial studies
This study focuses on the remote monitoring of patient-reported outcomes (PROs) for individuals undergoing radiation therapy for breast and prostate cancer. By utilizing a mobile application, patients can easily report their symptoms, allowing healthcare providers to monitor their condition in real-time and make timely decisions regarding their care. The goal is to improve symptom management and quality of life while reducing unnecessary hospital visits. This approach aims to enhance communication between patients and healthcare providers, ensuring that patients receive appropriate care when needed.
Who should consider this trial
Good fit: Ideal candidates for this study are patients diagnosed with breast or prostate cancer who are about to start radiation therapy and can use the mobile app in English or French.
Not a fit: Patients with significant comorbidities that make them unsuitable for remote monitoring may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to better symptom control and improved quality of life for patients undergoing radiation therapy.
How similar studies have performed: While the use of remote monitoring for chemotherapy patients has shown benefits, this specific approach for radiation therapy is novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Clinical diagnosis of breast or prostate cancer * About to receive a course of radical or adjuvant radiation therapy as an outpatient at Princess Margaret Cancer Centre * Able to enter PRO responses into the mobile app in English or French Exclusion Criteria: * Significant comorbidities that would render the patient not suitable for remote monitoring
Where this trial is running
Toronto, Ontario
- Princess Margaret Cancer Centre — Toronto, Ontario, Canada (Recruiting)
Study contacts
- Study coordinator: Tara Rosewall, PhD
- Email: tara.rosewall@rmp.uhn
- Phone: 416 946 2000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.